PRINCETON, NJ--(MARKET WIRE)--Jun 29, 2007 -- Barrier Therapeutics, Inc. (NasdaqGM:BTRX - News), a pharmaceutical company that develops and markets dermatology products, today announced that it has received a $12 million senior secured credit facility from Merrill Lynch Capital, a division of Merrill Lynch Business Financial Services Inc., to finance ongoing working capital requirements of its commercial operations.
